Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Affimed N.V.. (5/29/19). "Press Release: Affimed to Present at the Jefferies 2019 Healthcare Conference". Heidelberg.

Organisations Organisation Affimed N.V. (Nasdaq: AFMD)
  Group Affimed (Group)
  Organisation 2 Jefferies LLC
  Group Leucadia (Group)
Products Product Jefferies 2019 Global Healthcare Conference New York
  Product 2 ROCK® (Redirected Optimized Cell Killing) platform
Index term Index term Affimed–Leucadia: investor conference, 201906 supply service Affimed presents at Jefferies 2019 Global Healthcare Conference NY
Persons Person Hoess, Adi (Affimed 201109– CEO before CCO before Jenowis + Jerini 2003– + Carl Zeiss AG + MorphoSys AG)
  Person 2 Gin, Gregory (Affimed 201808 Head of Investor Relations)
     


Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced that its Chief Executive Officer, Dr. Adi Hoess, will present at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 10:00 a.m. Eastern Time.

A live webcast of the presentation can be accessed under the “News & Events” section of Affimed’s website at http://www.affimed.com/news-events/ and will be available for 30 days following the event.


About Affimed N.V.

Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. The Company is developing single and combination therapies to treat cancers. For more information, please visit www.affimed.com.


Affimed Investor Contact:
Gregory Gin, Head of Investor Relations
E-Mail: IR@affimed.com

Affimed Media Contact:
Anca Alexandru, Head of Communications, EU IR
E-Mail: media@affimed.com

   
Record changed: 2019-05-31

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Affimed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top